TAF
Tredje AP-fonden Portfolio holdings
AUM
$12.6B
This Quarter Return
-6.33%
1 Year Return
+20.01%
3 Year Return
+108.71%
5 Year Return
+188.48%
10 Year Return
+455.91%
AUM
$1.02B
AUM Growth
+$1.02B
(-18%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-13.46%
Top 10 Holdings %
Top 10 Hldgs %
23.28%
Holding
308
New
9
Increased
24
Reduced
263
Closed
10
Top Buys
| 1 |
Pfizer
PFE
|
$23.6M |
| 2 |
Gilead Sciences
GILD
|
$19.6M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.14M |
| 4 |
Bristol-Myers Squibb
BMY
|
$6.37M |
| 5 |
Amazon
AMZN
|
$4.55M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$31.9M |
| 2 |
Johnson & Johnson
JNJ
|
$13.4M |
| 3 |
Merck
MRK
|
$9.99M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
$9.22M |
| 5 |
Walt Disney
DIS
|
$7.5M |
Sector Composition
| 1 | Healthcare | 21.44% |
| 2 | Financials | 14.75% |
| 3 | Technology | 13.9% |
| 4 | Communication Services | 10.78% |
| 5 | Consumer Staples | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Merck
MRK
$212B
| $9.21M | 0.9% |
184,543
-200,175
| -52% | -$9.99M |
|
27
AT&T
T
$209B
| $9M | 0.88% |
276,209
-3,127
| -1% | -$102K |
|
28
PepsiCo
PEP
$208B
| $8.96M | 0.87% |
94,243
-10,333
| -10% | -$983K |
|
29
Visa
V
$678B
| $8.8M | 0.86% |
126,352
-10,528
| -8% | -$733K |
|
30
Cisco
CSCO
$270B
| $8.57M | 0.84% |
326,626
-226,785
| -41% | -$5.95M |
|
31
Philip Morris
PM
$257B
| $8.04M | 0.79% |
100,106
-8,086
| -7% | -$650K |
|
32
Oracle
ORCL
$631B
| $8.02M | 0.78% |
222,127
-24,486
| -10% | -$884K |
|
33
CVS Health
CVS
$94.5B
| $7.05M | 0.69% |
73,036
-7,935
| -10% | -$766K |
|
34
UnitedHealth
UNH
$283B
| $6.99M | 0.68% |
60,262
-6,651
| -10% | -$772K |
|
35
Altria Group
MO
$112B
| $6.94M | 0.68% |
126,196
-13,854
| -10% | -$762K |
|
|
AGN
36
DELISTED
Allergan plc
AGN
| $6.89M | 0.67% |
25,343
-894
| -3% | -$243K |
|
37
Boeing
BA
$179B
| $6.79M | 0.66% |
51,846
-5,659
| -10% | -$741K |
|
38
HP
HPQ
$26.3B
| $6.74M | 0.66% |
261,318
-123,017
| -32% | -$3.17M |
|
|
39
Bristol-Myers Squibb
BMY
$96.1B
| $6.43M | 0.63% |
107,944
+106,936
| +10,609% | +$6.37M |
|
40
Northrop Grumman
NOC
$84.1B
| $5.99M | 0.58% |
36,066
-3,924
| -10% | -$651K |
|
41
McDonald's
MCD
$224B
| $5.97M | 0.58% |
60,581
-6,674
| -10% | -$658K |
|
42
Mastercard
MA
$534B
| $5.9M | 0.58% |
65,446
-7,117
| -10% | -$641K |
|
43
Schlumberger
SLB
$54.1B
| $5.74M | 0.56% |
82,554
-9,041
| -10% | -$629K |
|
44
3M
MMM
$82.2B
| $5.71M | 0.56% |
40,277
-4,435
| -10% | -$629K |
|
45
Nike
NKE
$111B
| $5.49M | 0.54% |
44,503
-4,871
| -10% | -$600K |
|
46
Starbucks
SBUX
$99.4B
| $5.42M | 0.53% |
95,403
-10,489
| -10% | -$596K |
|
47
Eli Lilly
LLY
$652B
| $5.3M | 0.52% |
63,287
-6,933
| -10% | -$580K |
|
48
Booking.com
BKNG
$179B
| $4.98M | 0.49% |
4,026
+447
| +12% | +$553K |
|
49
Union Pacific
UNP
$131B
| $4.97M | 0.49% |
55,841
-6,092
| -10% | -$542K |
|
|
50
Johnson & Johnson
JNJ
$429B
| $4.96M | 0.48% |
53,180
-143,345
| -73% | -$13.4M |
|